Pancreatic Cancer: Progress in Systemic Therapy.

about

Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and Advancements.

P2860

Q37625297-4A270F07-7290-4881-BE08-BB9142215BDB

P2860

Pancreatic Cancer: Progress in Systemic Therapy.

Item

http://www.wikidata.org/entity/Q36344551

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Pancreatic Cancer: Progress in Systemic Therapy.

@ast

Pancreatic Cancer: Progress in Systemic Therapy.

@en

type

Item

label

Pancreatic Cancer: Progress in Systemic Therapy.

@ast

Pancreatic Cancer: Progress in Systemic Therapy.

@en

prefLabel

Pancreatic Cancer: Progress in Systemic Therapy.

@ast

Pancreatic Cancer: Progress in Systemic Therapy.

@en

P1476

Pancreatic Cancer: Progress in Systemic Therapy.

@en

P2093

Luka Perkhofer

http://www.w3.org/2001/XMLSchema#string

Thoma Seufferlein

http://www.w3.org/2001/XMLSchema#string

Thomas J Ettrich

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

P304

167-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000380785

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26672477

http://www.w3.org/2001/XMLSchema#string

P932

4668785

http://www.w3.org/2001/XMLSchema#string

Pancreatic Cancer: Progress in Systemic Therapy.

about

P2860

P2860

Pancreatic Cancer: Progress in Systemic Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932